Deletions and mutations in the tumor suppressor gene phosphatase and tensin homologue (PTEN), which encodes the PTEN protein, are among the most frequent alterations found in prostate cancer, particularly in the metastatic setting [1, 2, 3]. Here, PTEN is linked to prostate carcinoma.